Disclosure timeline3 days from execution to publication · legal deadline 2 business days
Nov 6 executedNov 9, 2026 disclosed
LXRX · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Other disclosed activity · LXRX
No records
No other disclosures for this security in the dataset.
Evidence
Verified data
Read directly from the primary public document; every field below is as reported by the filer.
Exton Michael filed this Form 4 reporting a open-market purchase of LXRX on Nov 6, 2026. It became public on Nov 9, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, Chief Executive Officer
Exton Michaelcik:0002029249
Issuer
LEXICON PHARMACEUTICALS INCcik:0001062822
Revision history · 0
No field has changed since this record was first ingested.
